BlackRock, Inc. Increases Stake in Verastem Inc. to 6%

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing an increased ownership of 6% in Verastem Inc. The filing indicates that BlackRock now holds 3,676,905 shares of Verastem's common stock, up from 1,740,104 shares previously. This represents a significant increase of 111.3% in both the number of shares and the value of the holdings. The filing also notes that the securities were acquired in the ordinary course of business and not for the purpose of influencing the control of Verastem Inc. The filing was signed by Spencer Fleming, Managing Director of BlackRock, Inc.